A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed

Active, not recruitingOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

January 16, 2019

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Melanoma
Trial Locations (14)

1000

Local Institution, Brussels

1090

Local Institution, Brussels

1210

Local Institution, Luxembourg

2020

Local Institution, Antwerp

2300

Local Institution, Turnhout

2650

Local Institution, Edegem

3500

Local Institution, Hasselt

4000

Local Institution, Liège

5004

Local Institution, Bouge

7100

Local Institution, La Louvière

9000

Local Institution, Ghent

9100

Local Institution, Sint-Niklaas

9300

Local Institution, Aalst

B-8000

Local Institution, Bruges

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY